Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Caution Regarding Forward Looking Statements
This
Form 10-Q
contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included or incorporated by reference in this
report
, including without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs and plans and objective of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” or “believes” or the negative thereof or any variation there on or similar terminology or expressions.
We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation,
the restatement of previously issued financial statements, the identified material weaknesses in our internal control over financial reporting and our ability to remediate those material weaknesses,
our ability to purchase defaulted consumer receivables at appropriate prices, changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables, our ability to employ and retain qualified employees, changes in the credit or capital markets, changes in interest rates, deterioration in economic conditions, negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and statements of assumption underlying any of the foregoing, as well as other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K
for the fiscal year ended September 30,
2017
.
All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise any forward-looking statements.
Overview
Asta Funding, Inc., together with its wholly owned significant operating subsidiaries Palisades Collection, LLC, Palisades Acquisition XVI, LLC (“Palisades XVI”), Palisades Acquisition XIX, LLC (“Palisades XIX”), Palisades Acquisition XXIII, LLC (“Palisades XXIII”), VATIV Recovery Solutions LLC (“VATIV”), ASFI Pegasus Holdings, LLC (“APH”), Fund Pegasus, LLC (“Fund Pegasus”), GAR Disability Advocates, LLC (“GAR Disability Advocates”), Five Star Veterans Disability, LLC (“Five Star”), EMIRIC, LLC (“EMIRIC”), Simia Capital, LLC (“Simia”), Sylvave, LLC (“Sylvave”), formerly known as Pegasus Funding, LLC (“Pegasus”), Practical Funding LLC (“Practical Funding”), and other subsidiaries, which are not all wholly owned (the “Company,” “we” or “us”), is engaged in several business segments in the financial services industry including funding of personal injury claims, through our wholly owned subsidiaries Sylvave, Simia and Practical Funding, social security and disability advocacy through our wholly owned subsidiaries GAR Disability Advocates and Five Star and the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, and semi-performing receivables.
GAR Disability Advocates and Five Star are disability advocacy groups, which for a fee obtain and represent individuals in their claims for social security disability, supplemental security income benefits from the Social Security Administration and veterans benefits with the Veteran's Administration.
Sylvave provided funding for individuals in need of short term funds pending insurance settlements of their personal injury claims. The funds are recouped when the underlying insurance settlements are paid. The long periods of time taken by insurance companies to settle and pay such claims resulting from lengthy litigation and the court process is fueling the demand for such funding. For the period October 1, 2017 to January 12, 2018, Sylvave was treated as an equity method investment. Commencing on January 13, 2018, Sylvave was consolidated in the Company’s financial statements.
In November 2016, the Company formed Simia, a 100% owned subsidiary. Simia commenced funding personal injury settlement claims in January 2017. Simia was formed in response to the Company’s decision not to renew its joint venture with Pegasus Legal Funding, LLC (“PLF”). Sylvave and Simia will remain in operation to collect its current portfolio of advances, but will not fund any new advances. The Company will continue its personal injury claims business with Practical Funding, a wholly owned subsidiary of the Company, which was formed on March 16, 2018. Through June 30, 2018, Practical Funding has not made any advances on personal injury claims.
On December 13, 2017, we sold all of our issued and outstanding equity capital in CBC, our wholly owned subsidiary engaging in structured settlements. As a result of this sale, all prior periods presented in our consolidated financial statements will account for CBC as a discontinued operation. This determination resulted in the reclassification of the assets and liabilities comprising our structured settlement business to assets and liabilities related to discontinued operations in the consolidated balance sheets, and a corresponding adjustment to our consolidated statements of operations to reflect discontinued operations for all periods presented. See Note 7 - Discontinued Operations.
The Company operates principally in the United States in three reportable business segments: consumer receivables, personal injury claims and social security benefit advocacy. The Company previously operated a fourth segment when it engaged in the structured settlements business through CBC prior to its sale on December 13, 2017.
Financial Information About Operating Segments
The Company operates through strategic business units that are aggregated into three reportable segments consisting of the following:
•
|
Consumer receivables
– This segment is engaged in the business of purchasing, managing for its own account and servicing distressed consumer receivables, including charged off and semi-performing receivables, primarily in the international marketplace. The charged-off receivables are accounts that have been written-off by the originators and may have been previously serviced by collection agencies. Semi-performing receivables are accounts where the debtor is currently making partial or irregular monthly payments, but the accounts may have been written-off by the originators. Distressed consumer receivables are the unpaid debts of individuals to banks, finance companies and other credit providers. These receivables were acquired at substantial discounts to their face values. The discounts are based on the characteristics (issuer, account size, debtor location and age of debt) of the underlying accounts of each portfolio. Litigation related receivables are semi-performing investments whereby the Company is assigned the revenue stream from the proceeds received. The business conducts its activities primarily under the name Palisades Collection, LLC.
|
•
|
Personal injury claims
– This segment is comprised of purchased interests in personal injury claims from claimants who were a party to personal injury litigation. The Company advances to each claimant funds on a non-recourse basis at an agreed upon interest rate, in anticipation of a future settlement. The interest in each claim purchased consists of the right to receive, from such claimant, part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Simia commenced funding personal injury settlement claims in January 2017 and ceased funding claims in June 2017, while Sylvave was acquired on January 12, 2018 and will not fund any new advances. The Company is continuing its personal injury claims business in a new entity, Practical Funding, which was formed on March 16, 2018.
|
•
|
Social Security benefit advocacy
– GAR Disability and Five Star are advocacy groups representing individuals nationwide in their claims for social security disability and supplemental social security income benefits from the Social Security and Veterans Administration.
|
The consumer receivables, personal injury claims and the social security benefit advocacy segments each accounted for 10% or more of consolidated net revenue for the three and nine months ended June 30, 2018 and 2017. Sylvave was accounted for under the equity method through January 12, 2018, and thereafter recorded on a consolidated basis within the personal injury claims segment, and as such is included in personal injury claims revenue below. The following table summarizes total revenues by percentage from the three lines of business for the three and nine months ended June 30, 2018 and 2017:
|
|
Three Month Ended
|
|
|
Nine Month Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
Finance income (consumer receivables)
|
|
|
62.2
|
%
|
|
|
74.4
|
%
|
|
|
70.3
|
%
|
|
|
73.9
|
%
|
Personal injury claims
|
|
|
21.4
|
%
|
|
|
4.5
|
%
|
|
|
11.9
|
%
|
|
|
1.5
|
%
|
Disability fee income
|
|
|
16.4
|
%
|
|
|
21.1
|
%
|
|
|
17.8
|
%
|
|
|
24.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Information about the results of each of the Company’s reportable segments for the three and nine month periods ended June 30, 2018 and 2017, reconciled to the Company’s consolidated results, are set forth below. Separate segment MD&A is not provided, as segment revenue corresponds to the revenue presented in the Company's consolidated statement of operations, and material expense items are not allocable to any specific segment.
(Dollars in millions)
|
|
Consumer
Receivables
|
|
|
Social
Security
Benefit
Advocacy
|
|
|
Personal Injury
Claims
(2)
|
|
|
Corporate
(3)
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
4.5
|
|
|
$
|
1.1
|
|
|
$
|
1.6
|
|
|
$
|
—
|
|
|
$
|
7.2
|
|
Other income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
0.1
|
|
|
|
0.1
|
|
Segment profit (loss)
|
|
|
3.6
|
|
|
|
0.3
|
|
|
|
1.1
|
|
|
|
(2.0
|
)
|
|
|
3.0
|
|
2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
4.0
|
|
|
|
1.1
|
|
|
|
0.3
|
|
|
|
—
|
|
|
|
5.4
|
|
Other income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
0.1
|
|
|
|
0.1
|
|
Segment profit (loss)
|
|
|
2.9
|
|
|
|
0.0
|
|
|
|
2.6
|
|
|
|
(3.7
|
)
|
|
|
1.8
|
|
Nine Months Ended June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
12.8
|
|
|
|
3.2
|
|
|
|
2.2
|
|
|
|
—
|
|
|
|
18.2
|
|
Other income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
0.2
|
|
|
|
0.2
|
|
Segment profit (loss)
|
|
|
11.4
|
|
|
|
0.5
|
|
|
|
1.9
|
|
|
|
(7.8
|
)
|
|
|
6.0
|
|
Segment Assets(1)
|
|
|
27.1
|
|
|
|
3.2
|
|
|
|
20.6
|
|
|
|
31.1
|
|
|
|
82.0
|
|
2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
|
12.0
|
|
|
|
4.0
|
|
|
|
0.3
|
|
|
|
—
|
|
|
|
16.3
|
|
Other income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
Segment profit (loss)
|
|
|
9.7
|
|
|
|
(1.4
|
)
|
|
|
2.3
|
|
|
|
(17.7
|
)
|
|
|
(7.1
|
)
|
Segment Assets(1) (4)
|
|
19.6
|
|
|
|
3.3
|
|
|
|
52.9
|
|
|
|
136.9
|
|
|
|
212.7
|
|
The Company does not have any intersegment revenue transactions.
(1)
|
Includes other amounts in other line items on the consolidated balance sheet.
|
(2)
|
The Company recorded Pegasus as an equity investment in its consolidated financial statements through January 12, 2018. Commencing on January 13, 2018, Sylvave is consolidated in the Company’s financial statements. For segment reporting the Company has included its pro-rated share of the earnings and losses from its investment under the Personal Injury Claims segment.
|
(3)
|
Corporate is not part of the three reportable segments, as certain expenses and assets are not earmarked to any specific operating segment.
|
(4)
|
Included in Corporate are approximately $93.7 million of assets related to discontinued operations as of June 30, 2017.
|
Consumer Receivables
The consumer receivable portfolios generally consist of one or more of the following types of consumer receivables:
|
•
|
charged-off receivables —
accounts that have been written-off by the originators and may have been previously serviced by collection agencies; and
|
|
•
|
semi-performing receivables —
accounts where the debtor is making partial or irregular monthly payments, but the accounts may have been written-off by the originators.
|
We acquire these consumer receivable portfolios at a significant discount to the amount actually owed by the borrowers. We acquire these portfolios after a qualitative and quantitative analysis of the underlying receivables and calculate the purchase price so that our estimated cash flow offers us an adequate return on our investment after servicing expenses. After purchasing a portfolio, we actively monitor its performance and review and adjust our collection and servicing strategies accordingly.
We purchase receivables from credit grantors and others through privately negotiated direct sales, brokered transactions and auctions in which sellers of receivables seek bids from several pre-qualified debt purchasers. We pursue new acquisitions of consumer receivable portfolios on an ongoing basis through:
|
•
|
our relationships with industry participants, financial institutions, collection agencies, investors and our financing sources;
|
|
•
|
brokers who specialize in the sale of consumer receivable portfolios; and
|
Litigation Funding Business
In 2011, the Company purchased an 80% interest in Pegasus. PLF, an unrelated third party, held the other 20% interest. The Company accounted for this investment under the equity method of accounting from the date of acquisition through January 12, 2018. See Note 4 - Litigation funding. The Company was committed to loan up to $22.4 million per year to Pegasus for a term of five years, all of which was secured by the assets of Pegasus. These loans provided financing for the personal injury litigation claims and operating expenses of Pegasus.
The Pegasus business model entails the outlay of non-recourse advances to a plaintiff with an agreed-upon fee structure to be repaid from the plaintiff’s recovery. Typically, such advances to a plaintiff approximate 10-20% of the anticipated recovery. These funds are generally used by the plaintiff for a variety of urgent necessities, ranging from surgical procedures to everyday living expenses.
Pegasus’s profits and losses were distributed at 80% to the Company and 20% to PLF. These distributions were made only after the repayment of Fund Pegasus’ principal amount loaned, plus an amount equal to advances for overhead expenses.
On November 8, 2016, the Company entered into a binding Term Sheet (the “Term Sheet”) with ASFI Pegasus Holdings, LLC, Fund Pegasus, LLC, Pegasus Funding, LLC, Pegasus Legal Funding, LLC, Max Alperovich and Alexander Khanas. The Company and PLF have decided not to renew the Pegasus joint venture that, by its terms, was scheduled to terminate on December 28, 2016. The Term Sheet amended certain provisions to Pegasus’ Operating Agreement dated as of December 28, 2011 and governed the terms relating to the liquidation of the existing Pegasus portfolio.
Pursuant to the Term Sheet, the parties thereto have agreed that Pegasus would continue in existence in order to collect advances on its existing Portfolio. The Company would fund overhead expenses relating to the collection of its Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus would be distributed to its members in the order provided for in the Operating Agreement. The Company was to be repaid an amount equal to 20% of all principal collected on each investment paid back beginning October 1, 2016 and continuing through the collection of the Portfolio, which would be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After January 2, 2017, additional overhead expenses advanced would be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits.
In connection with the Term Sheet, the parties thereto also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the operating agreement.
The Company filed for arbitration with the American Arbitration Association ("AAA") against Pegasus in April 2017 for breaches in the Operating Agreement and Term Sheet. On April 18, 2017, the Company was granted an Emergent Award restraining the cash in Pegasus, until a formal arbitration panel was confirmed and could review the case. Immediately prior to acquisition there was approximately $38.3 million in cash that was restrained under the Emergent Award. See Note 4 - Litigation Funding.
On July 17, 2017, an arbitration panel was confirmed, and a hearing date was scheduled for August 25, 2017 on the Company's motion to have PLF removed from managing Pegasus and replacing them with Company designated representatives, and to permit disbursements to the Company in accordance with the Operating and Liquidation Agreements.
On January 12, 2018, the Company, ASFI and Fund Pegasus entered into a Settlement Agreement and Release (the “Settlement Agreement”) by and among the Company, ASFI, Fund Pegasus, Pegasus, the Seller, Max Alperovich, Alexander Khanas, Larry Stoddard, III, Louis Piccolo and A.L. Piccolo & Co., Inc., a New York corporation. The Settlement Agreement released certain claims in exchange for, among other things, the parties' entry into the Purchase Agreement.
Additionally, on January 12, 2018, ASFI Pegasus Holdings, LLC (“ASFI”), a Delaware limited liability company and a subsidiary of Asta Funding, Inc. (the “Company” or “Asta”), a Delaware corporation, entered into a Membership Interest Purchase Agreement (the “Purchase Agreement) with Pegasus Legal Funding, LLC, a Delaware limited liability company (the “Seller”). Under the Purchase Agreement, ASFI bought the Seller’s ownership interests of Pegasus Funding, LLC (“Pegasus”), which was 20% of the issued and outstanding limited liability company interests of Pegasus, for an aggregate purchase price of $1.8 million. As a result of the execution of the Purchase Agreement, ASFI became the owner of 100% of the limited liability company interests of Pegasus. Upon the acquisition the Company recognized a loss of $1.4 million, and acquired assets of approximately $20.3 million and assumed liabilities of $0.7 million.
As of January 12, 2018, the Company owns 100% of Pegasus, changed its name to Sylvave and commencing in the quarter ending March 31, 2018, the financial activity of Sylvave will be consolidated into the financial statements of the Company. As of January 12, 2018, the Company is entitled to 100% of all distributions made from Pegasus.
On November 11, 2016, the Company formed Simia, a wholly owned subsidiary. Simia commenced operations in January 2017, and conducts its business solely in the United States. Simia obtains its business from external brokers and internal sales professionals soliciting individuals with personal injury claims. Business is also obtained from its website and through attorneys. The Company accounted for its investment in Sylvave under the equity method of accounting through January 12, 2018, for subsequent periods the Company will include the financial results of Sylvave in its consolidated statement of operations. The Company formed a new entity Practical Funding on March 16, 2018 to continue in the personal injury claims funding business. As of June 30, 2018, the Company’s net investment in personal injury cases was approximately $13.8 million. Through June 30, 2018, Practical Funding has not made any advances on personal injury claims.
On May 8, 2012, the Company announced the formation of EMIRIC, LLC, a wholly owned subsidiary of the Company. EMIRIC, LLC entered into a joint venture (the “Venture”) with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create the operating subsidiary BP Case Management, LLC (“BPCM”). BPCM is 60% owned by the Company and 40% owned by BP Divorce Funding. The Venture provides non-recourse funding to a spouse in a matrimonial action where the marital assets exceed $2,000,000. Such funds can be used for legal fees, expert costs and necessary living expenses. The Venture receives an agreed percentage of the proceeds received by such spouse upon final resolution of the case. BP Divorce Funding's profits and losses will be distributed 60% to BPCM and 40% to BP Divorce Funding, after the return of the Company’s investment on a case by case basis and after a 15% preferred return to the Company. BPCM’s initial investment in the Venture consisted of up to $15 million to fund divorce claims to be fulfilled in three tranches of $5 million each. Each investment tranche is contingent upon a minimum 15% cash-on-cash return to us. At the Company’s option, there could be an additional $35 million investment in divorce claims in tranches of $10 million, $10 million, and $15 million, also with a 15% preferred return and such investments may even exceed a total of $50 million, at BPCM’s sole option. Should the preferred return be less than 15% on any $5 million tranche, the 60%/40% profit and loss split would be adjusted to reflect BPCM’s priority to a 15% preferred return. As of June 30, 2018, BPCM had fully reserved against its invested amount of approximately $2.5 million. There was no income recognized for the three and nine months ended June 30, 2018 and 2017.
In 2012, the Company provided a $1.0 million revolving line of credit to partially fund BP Divorce Funding’s operations with such loan bearing interest at the prevailing prime rate with an initial term of twenty four months. In September 2014, the agreement was revised to extend the term of the loan to August 2017, increase the credit line to $1.5 million and include a personal guarantee of the principal of BP Divorce Funding. The revolving line of credit is collateralized by BP Divorce Funding’s profits share in the venture and other assets. At December 31, 2016, the balance in the revolving line of credit was approximately $1.5 million. Effective August 14, 2017, the Company extended its revolving line of credit with BP Divorce Funding until March 31, 2017, at substantially the same terms as the September 2014 amendment. On April 1, 2017, BP Divorce Funding defaulted on this agreement, and as such, the loan balance of approximately $1.5 million was deemed uncollectible and was written off to general and administrative expenses on the consolidated statement of operations during the year ended September 30, 2017.
Disability Advocacy Business
GAR Disability Advocates and Five Star are disability advocacy groups, which for a fee obtain and represent individuals in their claims for social security disability, supplemental security income benefits from the Social Security Administration and veterans benefits with the Veteran’s Administration.
Critical Accounting Policies
We may account for our investments in consumer receivable portfolios, using either:
|
•
|
The interest method; or
|
|
•
|
The cost recovery method.
|
Our extensive liquidating experience in certain asset classes such as distressed credit card receivables, consumer loan receivables and mixed consumer receivables has matured, we use the interest method when we believe we can reasonably estimate the timing of the cash flows. In those situations where we diversify our acquisitions into other asset classes in which we do not possess the same expertise or history, or we cannot reasonably estimate the timing of the cash flows, we utilize the cost recovery method of accounting for those portfolios of receivables.
The Company accounts for certain of its investments in finance receivables using the interest method under the guidance of FASB Accounting Standards Codification (“ASC”) Topic 310, Receivables — Loans and Debt Securities Acquired with Deteriorated Credit Quality, (“ASC 310”). Under the guidance of ASC 310, static pools of accounts are established. These pools are aggregated based on certain common risk criteria. Each static pool is recorded at cost and is accounted for as a single unit for the recognition of income, principal payments and loss provision. Due to the substantial reduction of portfolios reported under the interest method, and the inability to reasonably estimate cash collections required to account for those portfolios under the interest method, the Company concluded the cost recovery method is the appropriate accounting method under the circumstances.
Under the guidance of ASC 310, the Company must analyze a portfolio upon acquisition to ensure which method is appropriate, and once a static pool is established for a quarter, individual receivable accounts are not added to the pool (unless replaced by the seller) or removed from the pool (unless sold or returned to the seller).
The Company uses the cost recovery method when collections on a particular pool of accounts cannot be reasonably predicted. Under the cost recovery method, no income is recognized until the cost of the portfolio has been fully recovered. A pool can become fully amortized (zero carrying balance on the balance sheet) while still generating cash collections. In this case, all cash collections are recognized as revenue when received.
The Company accounts for its investments in personal injury claims at an agreed upon interest rate, in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. Open case revenue is estimated, recognized and accrued at a rate based on the expected realization and underwriting guidelines and facts and circumstances for each individual case. These personal injury claims are non-recourse. When a case is closed and the cash is received for the advance provided to a claimant, revenue is recognized based upon the contractually agreed upon interest rate, and, if applicable, adjusted for any changes due to a settled amount and fees charged to the claimant.
Management assesses the quality of the personal injury claims portfolio through an analysis of the underlying personal injury fundings on a case by case basis. Cases are reviewed through periodic updates with attorneys handling the cases, as well as with third party research tools which monitor public filings, such as motions or judgments rendered on specific cases. The Company specifically reserves for those fundings where the underlying cases are identified as uncollectible, due to anticipated non-favorable verdicts and/or settlements at levels where recovery of the advance outstanding is unlikely. For cases that have not exhibited any specific negative collection indicators, the Company establishes reserves based on the historical collection rates of the Company’s fundings. Fee income on advances is reserved for on all cases where a specific reserve is established on the initially funded amount. In addition, management also monitors its historical collection rates on fee income and establishes reserves on fee income consistent with the historically experienced collection rates. Management regularly analyzes and updates the historical collection rates of its initially funded cases as well as its fee income.
Prior to its sale, CBC purchased periodic payments under structured settlements and annuity policies from individuals in exchange for a lump sum payment. The Company elected to carry structured settlements at fair value. Unearned income on structured settlements is recognized as interest income using the effective interest method over the life of the related settlement. Changes in fair value are recorded in unrealized gain (loss) in structured settlements in our statements of income.
The Company recognizes revenue for GAR Disability Advocates when cases close and fees are collected.
The Company accounts for its impairments in accordance with ASC 310, which provides guidance on how to account for differences between contractual and expected cash flows from an investor’s initial investment in loans or debt securities acquired in a transfer if those differences are attributable, at least in part, to credit quality. The recognition of income under ASC 310 is dependent on the Company having the ability to develop reasonable expectations of both the timing and amount of cash flows to be collected. In the event the Company cannot develop a reasonable expectation as to both the timing and amount of cash flows expected to be collected, ASC 310 permits the change to the cost recovery method. The Company will recognize income only after it has recovered its carrying value. If collection projections indicate the carrying value will not be recovered, an impairment is required. The impairment will be equal to the difference between the carrying value at the time of the forecast and the corresponding estimated remaining future collections. During the three and nine months ended June 30, 2018 the Company impaired one domestic portfolio which resulted in a charge to expense of $100,000.
In the following discussions, most percentages and dollar amounts have been rounded to aid in the presentation. As a result, all figures are approximations.
Results of Operations
Nine
Months Ended
June 30, 2018
, Compared to the
Nine
Months Ended
June 30
,
2017
Finance income
. For the nine months ended June 30, 2018, finance income increased $0.8 million or 6.7% to $12.8 million from $12.0 million for the nine months ended June 30, 2017. During the nine months ended June 30, 2018, the Company did not purchase any portfolios. During the first nine months of fiscal year 2017, the Company purchased $35.0 million of face value portfolios at a cost of $2.2 million. Net collections for the nine months ended June 30, 2018 decreased, $3.5 million, or 19.1%, to $14.8 million from $18.3 million for the same prior year period. During the first nine months of fiscal year 2018, gross collections decreased 16.9% or $5.5 million to $27.1 million from $32.6 million for the nine months ended June 30, 2017. Commissions and fees associated with gross collections from our third party collection agencies and attorneys decreased $2.0 million, or 14.0%, to $12.3 million for the current fiscal nine month period from $14.3 million for the nine months ended June 30, 2017. Commissions and fees amounted to 45.0% of gross collections for the nine month period ended June 30, 2018, compared to 43.8% in the same period of the prior year, resulting from higher percentage of commissionable collections in the current year period.
Disability
fee income.
For the nine months ended June 30, 2018, disability fee income decreased $0.8 million, or 20.0%, to $3.2 million as compared to $4.0 million for the nine months ended June 30, 2017, due to the decrease in the number of disability claimant cases closed with the Social Security Administration during the current period.
Earnings (loss) from equity method invest
ment
. Earnings from our historical equity method investment decreased $2.0 million, or 71.4%, to earnings of $0.8 million for the nine months ended June 30, 2018 from earnings of $2.8 million for the nine months ended June 30, 2017, due to acquisition of the remaining 20% of the non controlling interest on January 12, 2018 and subsequent income being recorded as part of our personal injury claims income in the consolidated statement of operations.
Other income
(loss)
,
net
.
The following table summarizes other income (loss) for the nine months ended June 30, 2018 and 2017:
|
|
June 30,
|
|
|
|
2018
|
|
|
2017
|
|
Interest and dividend income
|
|
$
|
235,000
|
|
|
$
|
733,000
|
|
Realized loss
|
|
|
—
|
|
|
|
(833,000
|
)
|
Other
|
|
|
(56,000
|
)
|
|
|
(26,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
$
|
179,000
|
|
|
$
|
(126,000
|
)
|
During the nine months ended June 30, 2018, interest income was primarily earned on the Company's note receivable from its sale of CBC.
General and administrative expenses.
For the nine months ended June 30, 2018, general and administrative expense decreased $13.9 million, or 54.3%, to $11.7 million from $25.6 million for the nine months ended June 30, 2017, primarily due to a decrease in bad debt expense of $4.7 million (mainly the prior year Topaz loss of $3.4 million and BPCM loss of $1.5 million), professional fees of $3.9 million, (primarily related to the Mangrove matter), collection expenses $0.8 million, payroll related expenses $2.5 million, advertising $0.6 million and other operational expenses $1.4 million.
Interest expense
. For the nine months ended June 30, 2018, interest expense decreased $178,000 to $19,000 as compared to $197,000 for the nine months ended June 30, 2017. The decreased interest expense is a result of the Company's payoff of its line of credit in August of 2017.
Segment profit
– Consumer Receivables
. For the nine months ended June 30, 2018, segment profit increased $1.7 million to $11.4 million from $9.7 million for the nine months ended June 30, 2017, primarily due the reduction in collection costs of $0.9 million, and increase in revenues of $0.8 million.
Segment
profit
– Personal Injury Claim
s
. For the nine months ended June 30, 2018, segment profit was $1.9 million as compared to segment profit of $2.3 million for the nine months ended June 30, 2017. The decrease is attributable to the Company's decrease in revenue in the current period, primarily related to the lack of new fundings in the current period.
Segment
profit (
loss
)
–
Social Security Benefit Advocacy
. For the nine months ended June 30, 2018, segment profit was $0.5 million as compared to a $1.4 million loss for the same period in the prior year. This reduced loss in the current period is primarily the result of decreased revenues of $0.8 million offset by reduction in overhead expenses of $2.7 million (payroll related of $1.6 million, advertising of $0.6 million, postage of $0.3 million and other operational expenses of $0.2 million).
Income tax
(benefit)
expense
. For the nine months ended June 30, 2018, income tax expense for continuing and discontinued operations, consisting of federal and state income taxes, was $5.6 million, as compared to an income tax benefit for continuing and discontinued operations, consisting of federal and state income taxes, was $1.3 million for the nine months ended June 30, 2017, resulting from a decrease in the taxable loss in the current period.
Income
from continuing operations
. As a result of the above, the Company had a net income from continuing operations for the nine months ended June 30, 2018 of $0.4 million compared to $7.0 million net loss from continuing operations for the nine months ended June 30, 2017.
Loss
from
discontinued
operations
. As a result of the above, the Company had a net loss from discontinued operations for the nine months ended June 30, 2018 of $0.1 million compared to $1.8 million of net loss from discontinued operations for the nine months ended June 30, 2017.
Net
income
.
As a result of the above, the Company had a net income for the nine months ended June 30, 2018 of $0.3 million compared to $8.8 million net loss for the nine months ended June 30, 2017.
T
hree
Months Ended
June 30, 2018
, Compared to the Three
Months Ended
June 30
,
2017
Finance income
. For the three months ended June 30, 2018, finance income increased $0.5 million or 12.5% to $4.5 million from $4.0 million for the three months ended June 30, 2017. During the three months ended June 30, 2018 and 2017, the Company did not purchase any portfolios. Net collections for the three months ended June 30, 2018, decreased $1.0 million, or 16.4%, to $5.1 million from $6.1 million for the three months ended June 30, 2017. During the second quarter of fiscal year 2018, gross collections decreased 10.3%, or $1.1 million, to $9.6 million from $10.7 million for the three months ended June 30, 2017. Commissions and fees associated with gross collections from third party collection agencies and attorneys decreased to $0.2 million for the three months ended June 30, 2018 from $4.6 million for the three months ended March 31, 2017 to $4.4 million at June 30, 2018. Commissions and fees amounted to 46.1% of gross collections for the three months ended June 30, 2018, compared to 43.1% for the three months ended June 30, 2017, resulting from higher percentage of commissionable collections in the current period.
Disability
fee income.
For the three months ended June 30, 2018 and 2017, disability fee income was $1.1 million.
Earnings (loss) from equity method invest
ment
. No earnings from our historical equity method investment were recorded during the three months ended June 30, 2018 due to the acquisition of the remaining 20% of the non-controlling interest on January 12, 2018 and subsequent income being recorded as part of our personal injury claims income in the consolidated statement of operations. For the three months ended June 30, 2017 the earnings from equity method investment was $2.7 million.
Other income
(loss)
, net
.
The following table summarizes other income (loss) for the three months ended June 30, 2018 and 2017:
|
|
June 30,
|
|
|
|
2018
|
|
|
2017
|
|
Interest and dividend income
|
|
$
|
111,000
|
|
|
$
|
61,000
|
|
Realized loss
|
|
|
—
|
|
|
|
(18,000
|
)
|
Other
|
|
|
(35,000
|
)
|
|
|
47,000
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
76,000
|
|
|
$
|
90,000
|
|
During the three months ended June 30, 2018, interest income was primarily earned on the Company's note receivable from its sale of CBC.
General and administrative expenses.
For the three months ended June 30, 2018, general and administrative expense decreased $1.9 million, or 31.1%, to $4.2 million from $6.1 million for the three months ended June 30, 2017, primarily attributable to reduction in bad debt expenses of $0.5 million, professional fees of $0.3 million, payroll $0.6 million, collection expenses $0.1 million and reduction in other overhead expenses $0.4 million.
Interest
expense
. For the three months ended June 30, 2018, interest expense decreased $147,000 to $17,000 as compared to $164,000 for the three months ended June 30, 2017. The decreased interest expense in the current period is the result of the Company's payoff of the advance on its line of credit in August, 2017.
Segment profit
– Consumer
Receivables
. For the three months ended June 30, 2018, segment profit increased $0.7 million to $3.6 million as compared to $2.9 million for the three months ended June 30, 2017, primarily due to the increased revenue $0.4 million and reduction in collection expenses $0.3 million.
Segment
profit
– Personal Injury Claims
. For the three months ended June 30, 2018, segment profit was $1.1 million as compared to segment profit of $2.6 million for the three months ended June 30, 2017. The decrease is attributable to the Company's decrease in revenue in the current period, primarily related to the lack of new fundings in the current period.
Segment
profit
–
Social Security Benefit Advocacy
. For the three months ended June 30, 2018, segment profit was $0.3 million as compared to break even for the same period in the prior year. This increase in income in the current fiscal year is primarily the result of increased revenues of $0.1 million and a reduction in the overhead expenses.
Income tax
expense
. For the three months ended June 30, 2018, income tax expense for continuing operations, consisting of federal and state income taxes, was $1.1 million, as compared to an income tax expense for continuing and discontinued operations, consisting of federal and state income taxes, was $0.6 million for the three months ended June 30, 2017, resulting from an increase in the taxable income in the current period.
Income
from continuing operations
. As a result of the above, the Company had a net income from continuing operations for the three months ended June 30, 2018 of $2.0 million compared to $1.6 million net income from continuing operations for the three months ended June 30, 2017.
Income
from
discontinued
operations
. As a result of the above, the Company had no net income or loss from discontinued operations for the three months ended June 30, 2018 as compared to $0.6 million of net income from discontinued operations for the three months ended June 30, 2017.
Net
income
.
As a result of the above, the Company had a net income for the three months ended June 30, 2018 of $2.0 million compared to $2.1 million net income for the three months ended June 30, 2017.
Liquidity and Capital Resources
Our primary source of cash from operations is collections on the receivable portfolios we have acquired and the funds generated from the liquidation of our personal injury claim portfolios. Our primary uses of cash included the payment of a special dividend to stockholders, as well as costs involved in the collection of consumer receivables, and to support the day-to-day operations of the Company.
Receivables Financing Agreement (“RFA”)
In March 2007, Palisades XVI borrowed approximately $227 million under the RFA, as amended in July 2007, December 2007, May 2008, February 2009, October 2010 and August 2013 from BMO, in order to finance the Portfolio Purchase which had a purchase price of $300 million. The original term of the agreement was three years. This term was extended by each of the Second, Third, Fourth, and Fifth Amendments and the most recent agreement signed in August 2013, discussed below.
Financing Agreement. The Settlement Agreement and Omnibus Amendment (“Settlement Agreement”) was in effect on August 7, 2013, Palisades XVI, a 100% owned bankruptcy remote subsidiary, entered into a Settlement Agreement with BMO as an amendment to the RFA. In consideration for a $15 million prepayment funded by the Company, BMO has agreed to significantly reduce minimum monthly collection requirements and the interest rate. If and when BMO were to receive the next $15 million of collections from the Portfolio Purchase, (the “Remaining Amount”) less certain credits for payments made prior to the consummation of the Settlement Agreement, the Company would be entitled to recover from future net collections the $15 million prepayment that it funded. Thereafter, BMO would have the right to receive 30% of future net collections. Upon repayment of the Remaining Amount to BMO, the Company would be released from the remaining contractual obligation of the RFA and the Settlement Agreement.
On June 3, 2014, Palisades XVI finished paying the Remaining Amount. The final principal payment of $2.9 million included a voluntary prepayment of $1.9 million provided from funds of the Company. Accordingly, Palisades XVI was entitled to receive $16.9 million of future collections from the Portfolio Purchase before BMO is entitled to receive any payments with respect to its Income Interest. During the month of June 2016, the Company received the balance of the $16.9 million, and, as of June 30, 2018, the Company recorded a liability to BMO of approximately $0.2 million, which was subsequently remitted on July 10, 2018 . The liability to BMO is recorded when actual collections are received.
Personal Injury Claims
On December 28, 2011, we formed a joint venture, Pegasus Funding, LLC (“Pegasus”), with Pegasus Legal Funding, LLC (“PLF”). Pegasus purchases interests in personal injury claims from claimants who are a party to personal injury litigation with the expectation of a settlement in the future. Pegasus advanced to each claimant funds on a non-recourse basis at an agreed upon interest rate in anticipation of a future settlement. The interest purchased by Pegasus in each claim will consist of the right to receive from such claimant part of the proceeds or recoveries which such claimant receives by reason of a settlement, judgment or award with respect to such claimant’s claim. The profits from the joint venture were distributed based on the ownership percentage of the parties — Asta Funding, Inc. 80% and PLF, 20%. The Company accounted for this investment under the equity method of accounting.
On November 8, 2016, the Company entered into a binding Term Sheet (the “Term Sheet”) with Pegasus and PLF. The Company and PLF have decided not to renew the Pegasus joint venture that by its terms was scheduled to terminate on December 28, 2016. The Term Sheet amended certain provisions to the Pegasus’ operating agreement dated as of December 28, 2011 (as amended, the “Operating Agreement”) and governed the terms relating to the collection of its existing Pegasus portfolio (the “Portfolio”).
Pursuant to the Term Sheet, the parties agreed that Pegasus would continue in existence to collect advances on its existing Portfolio. The Company would fund overhead expenses relating to the collection of the Portfolio based on a budget agreed upon by the Company and PLF. Any cash received by Pegasus will be distributed to its members in the order provided for in the Operating Agreement. The Company would be allocated an amount equal to 20% of all principal collected on each investment paid back beginning October 1, 2017 and continuing through the collection of the Portfolio, which will be applied against the outstanding balance of overhead expenses previously advanced by the Company to Pegasus. After January 2, 2017, additional overhead expenses advanced would be paid back monthly as incurred by the Company prior to the calculation and distribution of any profits.
In connection with the Term Sheet, the parties also entered into a customary mutual release and non-disparagement agreement as well as a release from the non-competition obligations under the Operating Agreement.
The Company filed for arbitration with the American Arbitration Association ("AAA") against Pegasus in April 2017 for breaches in the Operating and Term Sheet. On April 18, 2017, the Company was granted an Emergent Award restraining the cash in Pegasus, until a formal arbitration panel was confirmed and could review the case. Immediately prior to acquisition there was approximately $38.3 million in cash that was restrained under the Emergent Award.
On July 17, 2017, an arbitration panel was confirmed, and a hearing date was scheduled for August 25, 2017 on the Company's motion to have PLF removed from managing Pegasus and replacing them with Company designated representatives, and to permit disbursements to the Company in accordance with the Operating and Liquidation Agreements.
On January 12, 2018, the Company, ASFI and Fund Pegasus entered into a Settlement Agreement and Release (the “Settlement Agreement”) by and among the Company, ASFI, Fund Pegasus, Pegasus, the Seller, Max Alperovich, Alexander Khanas, Larry Stoddard, III, Louis Piccolo and A.L. Piccolo & Co., Inc., a New York corporation. The Settlement Agreement released certain claims in exchange for, among other things, the parties' entry into the Purchase Agreement.
Additionally, on January 12, 2018, ASFI Pegasus Holdings, LLC (“ASFI”), a Delaware limited liability company and a subsidiary of Asta Funding, Inc. (the “Company” or “Asta”), a Delaware corporation, entered into a Membership Interest Purchase Agreement (the “Purchase Agreement) with Pegasus Legal Funding, LLC, a Delaware limited liability company (the “Seller”). Under the Purchase Agreement, ASFI bought the Seller’s ownership interests of Pegasus, which was 20% of the issued and outstanding limited liability company interests of Pegasus, for an aggregate purchase price of $1.8 million. After the additional purchase of the minority member's 20% share, the Company became the 100% owner of Pegasus. Immediately upon acquisition, the Company changed the name of the entity to Sylvave. The Company acquired $20.3 million in assets and assumed $0.7 million in liabilities. The Company recognized a loss on acquisition of $1.4 million, which is recorded in the Company’s consolidated financial statements.
Divorce Funding
On May 8, 2012, the Company formed EMIRIC, LLC, a wholly owned subsidiary of the Company. EMIRIC, LLC entered into a joint venture with California-based Balance Point Divorce Funding, LLC (“BP Divorce Funding”) to create the operating subsidiary BP Case Management, LLC (“BPCM”). BPCM is 60% owned by the Company and 40% owned by BP Divorce Funding. BPCM provides non-recourse funding to a spouse in a matrimonial action. The Company provided a $1.0 million revolving line of credit to partially fund BPCM’s operations, with such loan bearing interest at the prevailing prime rate, with an initial term of twenty-four months. In September 2014, the agreement was revised to extend the term of the loan to August 2017, increase the credit line to $1.5 million and include a personal guarantee of the principal of BP Divorce Funding. Effective August 14, 2017, the Company extended its revolving line of credit with BP Divorce Funding until March 31, 2017, at substantially the same terms as the September 2014 amendment. On April 1, 2017, BP Divorce Funding defaulted on this agreement, and as such, the loan balance of approximately $1.5 million was deemed uncollectible and was written off to general and administrative expenses on the consolidated statement of operations during the year ended September 30, 2017.
As of June 30, 2018, BPCM had fully reserved against its invested amount of approximately $2.5 million.
Discontinued Operations –
Structured Settlements
On December 13, 2017, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with CBC Holdings LLC, a Delaware limited liability company (the “Buyer”). Under the Purchase Agreement, the Company sold all of the issued and outstanding equity capital of CBC, its wholly owned subsidiary engaging in structured settlements, for an aggregate purchase price of approximately $10.5 million. Of the aggregate purchase price, approximately $4.5 million was paid in cash, and $5.8 million was paid under a promissory note at an annual interest rate of 7% to be paid quarterly to the Company and secured by a first priority security interest in and lien on such Buyer’s affiliates’ rights to certain servicing fees. The remaining amount of the aggregate purchase price was paid as reimbursement of certain invoices of CBC. The Company recognized a loss of approximately $2.4 million on the above sale of CBC for the year ended September 30, 2017.
Cash Flow
At June 30, 2018, our cash increased $12.7 million to $30.3 million from $17.6 million at September 30, 2017.
Net cash provided by operating activities was $3.3 million during the nine month period ended June 30, 2018, as compared to $9.8 million used in operating activities for the nine month period ended June 30, 2017. Net cash provided by investing activities was $43.3 million during the nine month period ended June 30, 2018, as compared to $54.3 million provided by investing activities during the nine month period ended June 30, 2017. The change in cash provided by investing activities is primarily due to the proceeds from sale of available for sale securities, partially offset by purchases of available for sale securities in the prior year period of $49.2 million, compared to the change in equity method investment, partially offset by the acquisition of the personal injury claims portfolio, and purchase of available for sale securities in the current period of $37.9 million. Cash used in financing activities during the three month period ended June 30, 2018, was $33.6 million as compared to $35.6 million used in financing activities in the same 2017 period. The current year use of cash is the result of the special dividend paid to stockholders of $35.4 million.
Our cash requirements have been and will continue to be significant and include external financing to operate various lines of business. Significant requirements include investment in personal injury claims, costs involved in the collections of consumer receivables, and investment in consumer receivable portfolios. Acquisitions recently have been financed through cash flows from operating activities. We believe we may secure credit facilities with financial institutions as we look to grow the Company, support current operations, and execute on our short and long term business initiatives. In the short term, we expect our cash balances will be sufficient to invest in personal injury claims, purchase portfolios and finance the disability advocacy business.
We believe our available cash resources and expected cash flows from operations will be sufficient to fund operations for the next twelve months. We do not expect to incur any material capital expenditures during the next twelve months.
We are cognizant of the current market fundamentals in the debt purchase and company acquisition markets which, because of significant supply and tight capital availability, could result in increased buying opportunities. The outcome of any future transaction(s) is subject to market conditions. In addition, due to these opportunities, we continue to seek opportunities with banking organizations and others on a possible financing loan facility.
Off Balance Sheet Arrangements
The Company did not have any off balance sheet arrangements.
Additional Supplementary Information:
We do not anticipate collecting the majority of the purchased principal amounts of our various portfolios. Accordingly, the difference between the carrying value of the portfolios and the gross receivables is not indicative of future revenues from these accounts acquired for liquidation. Since we purchased these accounts at significant discounts, we anticipate collecting only a portion of the face amounts.
For additional information regarding our methods of accounting for our investment in finance receivables, the qualitative and quantitative factors we use to determine estimated cash flows, and our performance expectations of our portfolios, see “
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies
” above.
Recent Accounting Pronouncements
In May 2014, the FASB issued an update to ASC 606, “Revenue from Contracts with Customers,” that will supersede virtually all existing revenue guidance. Under this update, an entity is required to recognize revenue upon transfer of promised goods or services to customers, in an amount that reflects the entitled consideration received in exchange for those goods or services. The guidance also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the customer contracts. This update is effective for annual reporting periods beginning after December 15, 2017 including interim periods within that reporting period. Early application is permitted for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period.
The Company has completed its initial assessment of the new standard, including a detailed review of the Company’s revenue streams to identify potential differences in accounting as a result of the new standard, and selected the modified retrospective method. Based on the Company’s initial assessment, we do not believe that the adoption of the standard and related amendments will have a significant impact on our revenue recognition patterns, assuming that our revenue streams will be similar to those currently in place are in effect at the time of our adoption. Through the date of adoption, we will continue to evaluate the impacts of the standard to ensure that our preliminary conclusions continue to remain accurate. Additionally, we will continue our assessment of the impact of the standard on our financial statement disclosures which are expected to be more extensive based on the requirements of the new standard.
In January 2016, the FASB issued Update No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Upon adoption of this ASU, the Company's investments will no longer be classified as available for sale, and any changes in fair value will be reflected in the Company's consolidated statement of operations.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which requires lessees to recognize right-of-use assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months. For a lease with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize a right-of-use asset and lease liability. Additionally, when measuring assets and liabilities arising from a lease, optional payments should be included only if the lessee is reasonably certain to exercise an option to extend the lease, exercise a purchase option or not exercise an option to terminate the lease. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842. ASU 2018-01 was issued to address concerns about the cost and complexity of complying with the transition provisions of ASU 2018-01. The standard becomes effective in for fiscal years beginning after December 15, 2019 and interim periods within those years and early adoption is permitted. The Company is in the process of reviewing its existing leases, including service contracts for embedded leases to evaluate the impact of this standard on its consolidated financial statements and the impact on regulatory capital.
In March 2016, the FASB issued ASU No. 2016-07, Simplifying the Transition to the Equity Method of Accounting , which eliminates the requirement to apply the equity method of accounting retrospectively when a reporting entity obtains significant influence over a previously held investment. The amendments in ASU 2016-07 are effective for public companies for fiscal years beginning after December 15, 2016 including interim periods therein. Early adoption is permitted. The new standard should be applied prospectively for investments that qualify for the equity method of accounting after the effective date. The adoption of this standard did not have a material impact on the Company's consolidated financial statements.
In March 2016, the FASB issued Update No. 2016-09, Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The adoption of this update did not have a material impact on the Company's consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The ASU requires an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Additionally, the ASU amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For the Company, this update will be effective for interim periods and annual periods beginning after December 15, 2019. Upon adoption, the Company expects that it will accelerate the recording of its credit losses in its financial statements.
In August 2016 the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments." This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The new standard is effective for fiscal years beginning after December 15, 2017. Early adoption is permitted. The new standard will require adoption on a retrospective basis unless it is impracticable to apply, in which case the Company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is in the process of evaluating the provisions of the ASU, but does not expect it to have a material effect on the Company’s consolidated statements of cash flows.
In January 2017, the FASB issued ASU No. 2017-01, Financial Instruments - Overall (Subtopic 825-10) Recognition and Measurement of Financial Assets and Financial Liabilities. The main objective in developing this update is enhancing the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The amendments in this update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. The effective date for this update is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The adoption of this update will not have a material impact on the Company’s consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The objective of this update is to simplify the subsequent measurement of goodwill, by eliminating step 2 from the goodwill impairment test. The amendments in this update are effective for annual periods beginning after December 15, 2019, and interim periods within those fiscal years. The Company does not believe this update will have a material impact on its consolidated financial statements.
In March 2017, the FASB issued ASU No. 2017-09, Compensation - Stock Compensation (Topic 718) Improvements to Employee Share Based Payment Accounting, to simplify and improve areas of generally accepted accounting principles for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The effective date for this update is for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The adoption of this update will not have a material impact on the Company's consolidated financial statements.
In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income (loss) to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017, and requires certain disclosures about stranded tax effects. ASU 2018-02 will be effective for the Company's fiscal year beginning October 1, 2019, with early adoption permitted, and should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Act is recognized. The adoption of this ASU is not expected to have a material impact on the Company's consolidated financial statements.
In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. This ASU modifies the disclosure requirements on fair value measurements. The ASU removes the requirement to disclose: the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy; the policy for timing of transfers between levels; and the valuation processes for Level 3 fair value measurements. The ASU requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This ASU is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company is currently evaluating the impact this guidance will have on its consolidated financial statements.